Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile

Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel

(2017) Marion Paolini et al.   International Journal of Nanomedicine

Drug Development of Therapeutic Monoclonal Antibodies

(2016) Diane R. Mould et al.   BIODRUGS

Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics

(2016) Katherine L. Gill et al.   CLINICAL PHARMACOKINETICS

Chemotherapy-induced peripheral neuropathy: Current status and progress

(2016) Jamie R. Brewer et al.   GYNECOLOGIC ONCOLOGY

Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination

(2016) Yi-Nan Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Antibody–drug conjugates for cancer therapy

(2016) Anish Thomas et al.   LANCET ONCOLOGY

Cellular distribution of injected PLGA-nanoparticles in the liver

(2016) Jin-Kyu Park et al.   Nanomedicine-Nanotechnology Biology and Medicine

Inter-patient variability in docetaxel pharmacokinetics: A review

(2015) Annemieke J.M. Nieuweboer et al.   CANCER TREATMENT REVIEWS

Safety of Nanoparticles in Medicine

(2015) Joy Wolfram et al.   CURRENT DRUG TARGETS

Immunosuppressive drug therapy – biopharmaceutical challenges and remedies

(2015) Saba Khan et al.   Expert Opinion on Drug Delivery

Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents

(2015) Andrew T Lucas et al.   Expert Opinion on Drug Metabolism & Toxicology

FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin

(2015) Michal Pyzik et al.   JOURNAL OF IMMUNOLOGY

Targeting FcRn for the modulation of antibody dynamics

(2015) E. Sally Ward et al.   MOLECULAR IMMUNOLOGY

RES blockade: A strategy for boosting efficiency of nanoparticle drug

(2015) Ting Liu et al.   Nano Today

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms

(2014) Sariah Liu et al.   CANCER TREATMENT REVIEWS

Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz

(2014) Panjasaram Naidoo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior

(2014) Huile Gao et al.   Expert Opinion on Drug Delivery

State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines

(2014) Charlene M. Dawidczyk et al.   JOURNAL OF CONTROLLED RELEASE

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

(2014) Samir Mitragotri et al.   NATURE REVIEWS DRUG DISCOVERY

Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid

(2013) Li Liu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles

(2013) Mark J. Ernsting et al.   JOURNAL OF CONTROLLED RELEASE

Matching cellular dimensions with molecular sizes

(2013) Michael Reth   NATURE IMMUNOLOGY

Engineering multifunctional nanoparticles: all-in-one versus one-for-all

(2013) Elizabeth Huynh et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin

(2013) Noriyuki Yokomichi et al.   Human Cell

Renal Transporters in Drug Development

(2012) Kari M. Morrissey et al.   Annual Review of Pharmacology and Toxicology

Loss of orally administered drugs in GI tract

(2012) Yogeshkumar Nanasaheb Gavhane et al.   SAUDI PHARMACEUTICAL JOURNAL

The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles

(2011) Kai Xiao et al.   BIOMATERIALS

In vivobiodistribution of nanoparticles

(2011) Joao Paulo Mattos Almeida et al.   Nanomedicine

Relieving PEGylation

(2011) Matthew C. Parrott et al.   Nature Chemistry

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

(2010) Ron J. Keizer et al.   CLINICAL PHARMACOKINETICS

Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake

(2009) Xavier Banquy et al.   Soft Matter

Controlled drug delivery in tissue engineering

(2007) Marco Biondi et al.   ADVANCED DRUG DELIVERY REVIEWS